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ABSTRACT

Keywords
breastfeeding
breast milk
infant feeding
newborn
phenylketonuria (PKU)
phenylalanine

Methods: Mothers’ thoughts, decisions, and experiences of breastfeeding their infants with PKU were collected through
telephone interviews. Interviews were transcribed verbatim, and data were analyzed using thematic descriptive analysis
in the context of PKU.

Objective: To describe the meaning and importance of breastfeeding to mothers of infants with phenylketonuria (PKU).
Design: Qualitative description.
Setting: Mothers from the United States and Canada were recruited from the PKU Listserv and interviewed by
telephone.
Participants: Ten breastfeeding mothers with infants who had PKU and were younger than age 36 months.

Results: Participants felt that that breastfeeding an infant with PKU was the healthiest choice and was therefore worth
the labor. These women believed that this was what a loving mother would choose. As they continued to breastfeed
their infants after diagnosis, the views of the participants changed. Initially they saw PKU as a disorder and felt that
their infants were ill; later they felt that their infants were healthy in spite of PKU. Normal could mean a breastfeeding
infant with PKU.
Conclusion: Findings demonstrate the importance mothers attribute to breastfeeding and their willingness to invest
considerable effort to breastfeed. Health care providers working with these mothers should help them strategize for
success.
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henylketonuria (PKU) is an autosomal recessive condition related to the metabolism of
amino acid. This condition results from mutations
in the phenylalanine hydroxylase enzyme (PAH),
which is required to metabolize phenylalanine
(Phe) to tyrosine (Tyr) in the liver (Blau, van Spronsen, & Levy, 2010). As a result of the defective
PAH enzyme, Phe and its metabolites accumulate in the blood and eventually the brain and can
cause progressive cognitive-neurologic damage
in the infant.

P

The prevalence of PKU varies worldwide but is
present in every racial and ethnic group. The
greatest prevalence of PKU is in Ireland with
one case per 4,500 live births (Zschocke, Mallory, Eiken, & Nevin, 1997). Turkey follows closely
with one case per 5,000 live births (Tuncbilek &
Ozguc, 2007). Finland has the lowest prevalence
in Europe with less than one case per 100,000
births (Guldberg, Henriksen, Sipila, Guttler, & de
la Chapelle, 1995). In Latin America, the preva-

lence of PKU varies from one case per 25,000
births in Brazil to one case per 52,000 births in
Cuba (Borrajo, 2007). In comparison, the prevalence of PKU in Asia varies from one case per
15,000 to one case per 100,500 births in different
regions of China (Jiang et al., 2003; Zhan, Qin,
& Zhao, 2009) to one case per 327,000 births in
Thailand (Pangkanon, Charoensiriwatana, Janejai, Boonwanich, & Chaisomchit, 2009).
In the United States, the prevalence of PKU is approximately one case in 20,0000 live births but
varies from state to state due to the racial and ethnic makeup of the population (National Institutes of
Health Consensus Development Panel, 2001; National Newborn Screening and Genetics Resource
Center, 2009). The prevalence in Iowa is consistent with the national reported prevalence of approximately one case per 20,000 births (National
Newborn Screening and Genetics Resource Center, 2009), whereas in Louisiana, the prevalence
is approximately one case per 10,000 live births

in the White population and one case per 76,000
live births in the non-White population (Louisana
Office of Public Health, 2000). Overall, approximately 400 infants are born each year who are
positive for PKU in the United States.
In the United States newborn screening for PKU
is performed via tandem mass spectrometry on
dried blood spots. If a newborn has an abnormally elevated level of Phe (>190 μmol/L)
with an increased Phe-to-Tyr (ratio >3) on the
newborn screen, this is a presumptive positive result, and follow-up diagnostic testing and
assessment at a pediatric metabolic clinic is
needed as soon as possible (Northwest Regional
Newborn Screening Program, 2010). Follow-up
Phe testing is needed to measure Phe concentrations in the blood with positive diagnostic results
revealing increased Phe concentrations (>120
μmol/L) (Donlon, Levy, & Scriver, 2014).
Because the advent of newborn screening, infants with PKU can be diagnosed before an insidious neurocognitive insult occurs. During the
1960s and the early days of screening, the standard of care for infants diagnosed with PKU was
to wean them immediately from breastfeeding and
to institute feedings of low-Phe medical formula in
conjunction with standard commercial infant formula with the goal to maintain appropriate Phe levels (120–360 μmol/L) (Blau et al., 2010; Demirkol
et al., 2001; Kanufre et al., 2007). This management plan was believed to be the only effective
way to allow for precise titration and measurement of Phe to protect neurological and cognitive
development of infants with PKU. As researchers
demonstrated that breastfeeding and human
breast milk were viable options to the original practice of exclusive formula feeding, more mothers attempted to continue breastfeeding after diagnosis
(Cornejo et al., 2003; Ernest, McCabe, Neifert, &
O’Flynn, 1980; Greve, Wheeler, Green-Burgeson,
& Zorn, 1994; Kanufre et al., 2007; McCabe et al.,
1989; Motzfeldt, Lilje, & Nylander, 1999).
Although many mothers successfully continue to
breastfeed, many mothers decide not to continue
to breastfeed after the diagnosis of PKU (BantaWright, Press, Knafl, Steiner, & Houck, 2014). In
addition, investigators have consistently reported
that few mothers of infants with PKU persist in
breastfeeding beyond an initial period and breastfeed for a shorter duration than mothers of other
healthy term infants (Agostoni, Verduci, Fiori, Riva,
& Giovannini, 2000; Banta-Wright et al., 2014;
Banta-Wright, Shelton, Lowe, Knafl, & Houck,

Breastfeeding infants with phenylketonuria is challenging in
part because it is virtually impossible to precisely determine
phenylalanine intake.

2012; Cornejo et al., 2003; Demirkol et al., 2001;
Huner & Demirkol, 1996; Kanufre et al., 2007;
Motzfeldt et al., 1999; Segev, Abraham, Anikster,
& Schwartz, 2004; van Rijn et al., 2003).
The National Institutes of Health (2000) consensus statement on PKU encouraged breastfeeding in conjunction with the use of Phe-free
medical formula. In an international survey, MacDonald and colleagues (2006) examined the feeding recommendations of health care providers in
various metabolic centers in Europe, South America, United States, Australia, and New Zealand.
They found no universal approach to feeding infants with PKU. Treatment management varied
among countries and between metabolic centers
within countries. However, there was consensus
regarding the recommendation of Phe-free medical formula in combination with breastfeeding. In
2011, the National PKU Alliance published “My
PKU Binder,” a comprehensive resource for parents and individuals with PKU that briefly mentions that breast milk contains less Phe than standard commercial infant formula. This binder, a
trusted resource for mothers learning about PKU,
provides much needed general information about
PKU but lacks specific guidelines for successfully breastfeeding infants with PKU (e.g., guidance on maintaining a breast milk supply when
having to alter breast milk intake to maintain Phe
levels within the desired range).
Although PKU is a classic Mendelian disease, it
has variable clinical presentation and severity due
to the different mutations in the gene-encoding
PAH enzyme. The combinations of the different
mutations result in varying degrees of residual PAH activity level (Guldberg et al., 1994).
The residual PAH enzyme activity reflects Phe
tolerance. Phenylketonuria is classified based
upon the severity of the elevated Phe levels. The
normal range of blood Phe concentrations is 50 to
110 μmol/L (Donlon et al., 2014). There are four
different phenotypes: classical PKU, moderate
PKU, mild PKU, and mild hyperphenylalaninemia
(Blau, Hennermann, Langenbeck, & LichterKonecki, 2011). Yet classification during the
newborn period is difficult to determine as Phe
concentrations have not had time to reach their
peak values, and treatment is initiated before
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allowing the levels to peak. Usually by age 2 years,
the determination of the degree of Phe tolerance
is predictable (van Spronsen et al., 2009).
Breastfeeding an infant with PKU is challenging
and includes feeding at breast and bottle feeding expressed breast milk. Mothers typically offer
breast milk by one of three methods based upon
recommendations from their metabolic clinic.
(a) Mothers may provide a fixed amount of Phefree medical formula followed by breastfeeding
until satiety (Greve et al., 1994; Motzfeldt et al.,
1999), (b) provide a fixed amount of expressed
breast milk or a fixed time limitation of breastfeeding followed by Phe-free medical formula until satiety (Acosta & Yannicelli, 2001), and (c) or alternate
between breastfeeding and Phe-free medical formula feedings (van Rijn et al., 2003). All methods are dependent on the infant’s serial weekly to
twice weekly blood Phe levels. Generally, mothers obtain Phe specimens on their infants by performing heel sticks and forward the dried filter paper specimen to the laboratory for analysis. After
the laboratory receives the specimen, Phe results
are available in 24 to 48 hours. If the Phe level
is elevated or diminished based on the clinic’s
protocol, the clinic contacts the mother and the
dietary feeding plan is adjusted. If Phe levels are
elevated, breastfeeding is decreased; if levels are
diminished, breastfeeding is increased. Followup appointments for newborns with newly diagnosed PKU range from weekly for several weeks,
to every other week, to monthly by the first 12
months. These appointments are in addition to pediatric visits for regular newborn-infant care. During this time, mothers must breast pump frequently
enough to maintain their breast milk supply.
Although the investigators of breastfeeding
infants with PKU have focused on management
strategies to facilitate the adaption of breastfeeding while maintaining desired Phe levels, notably
absent are any studies to address the practice
of breastfeeding infants with PKU from mothers’
perspectives. Therefore, the purpose of this study
was to describe the meaning and importance of
breastfeeding to mothers of children with PKU.
Our goal was to consider the underlying mind-set
and beliefs that influence the decision to continue
to breastfeed after the diagnosis of PKU despite
challenges.

Methods
Design and Participants
This was a two-phase mixed methods study. The
first phase was an Internet survey completed by

mothers who had children with PKU and resided
in the United States and Canada. The goal of
the quantitative phase was to explore the rate of
breastfeeding before and after diagnosis of PKU in
a sample. In the sample, 119 mothers completed
a survey on their experiences feeding infants with
PKU. Of these mothers, 103 mothers had one child
with PKU whereas 16 mothers had two or more
children with PKU. Mothers with one child with
PKU ranged from age 21 to 63 years with a mean
of 35.6 ± 6.98 years and the majority were in their
thirties (n = 64, mode = 34). Nearly all the mothers
were married or partnered. In addition, the survey
sample reflected a well-educated group; all mothers were at least high school graduates, and more
than two thirds (n = 72) were college graduates.
Their infants were healthy term newborns with elevated Phe levels that ranged from 240 to 2,520
μmol/L with a mean of 948 ± 601 μmol/L on the
confirmatory testing after an abnormal newborn
screen. Initially 89 mothers breastfed, but after the
diagnosis, only 72 mothers continued to breastfeed. This decrease was significant (McNemar’s
χ2 = 30.333, p < .001; n = 72 vs. n = 89) (BantaWright et al., 2014).
The second phase of the study entailed qualitative
interviews with a subsample of mothers from the
survey. The goal of the interviews was to further
explore mothers’ breastfeeding experiences. For
the interviews, the inclusion criteria were at least
age 21 years or older and initiated breastfeeding an infant with PKU. There were no restrictions
on the length of time the mother had breastfed,
but only mothers of one child with PKU were recruited. In addition, the breastfed infant with PKU
needed to be younger than age 36 months at the
time of the interview. Of the 103 mothers who completed the survey and expressed a willingness to
be interviewed, 23 mothers met the sample criteria
for the qualitative phase of the study. Overall, the
23 mothers were predominately White, well educated, in their thirties, had breastfed for at least 4
months, and lived in various geographic regions
in the United States and Canada. Ten mothers
were selected to reflect a broad range of demographic variables: urban or rural residence, ethnicity, gravida status, education, marital status,
employment, and family income. Their infants were
healthy term infants with initial Phe levels ranging from 360 to 720 μmol/L. For this analysis, a
descriptive qualitative approach was used to describe the meaning and importance of breastfeeding for mothers of children with PKU. This study
was approved by the Oregon Health & Sciences
University Institutional Review Board.

Table 1: Sample Questions From Interview Guide
Family Management Topic

Question

Defining the Situation
Self

Tell me about your initial reaction to the PKU diagnosis.

Family

Tell me how you explained PKU to the members of your family and friends.

Child

Tell me how breastfeeding changed once the diagnosis of PKU was made.

Management Behaviors
Self

Tell me about your decision to continue breastfeeding your infant after the diagnosis of PKU.

Family

Tell me about the support or lack of support that you received in managing your infant’s PKU.

Child

Tell me about what it was like to breastfeed your infant with PKU.

Perceived Consequences
Self

Tell me about your perception of changes in how you parent or take care of the child with PKU.

Family

Tell me about the experience of PKU for your family.

Child

Tell me how you think PKU will affect your child as he/she grows.

Note. PKU = phenylketonuria.

Data Collection
Mothers who completed the Internet survey and
met the inclusion criteria were informed about the
study by the principal investigator. After obtaining informed consent from each mother, in-depth
telephone interviews were conducted and digitally recorded. The digitally recorded telephone
interviews ranged from 56 to 125 minutes with
a mean of 92 minutes. A detailed three-page interview guide was developed to reflect the study
purpose and objectives. A sample of the questions is provided in Table 1. In addition, mothers
were encouraged to expand on any topics they
introduced that were not included in the guide.
As a starting point, mothers were asked, “Tell me
about a typical day of breastfeeding your infant.”
This question was designed to elicit a full picture
of the day-to-day experience of breastfeeding an
infant with PKU. Probing questions were used to
gain a detailed description of the meaning participants ascribed to breastfeeding infants with PKU.
Field notes about the context (e.g., interruptions,
background noises) and tone of the interview were
recorded immediately after each interview. At the
completion of the interview, mothers were sent $20
gift certificates. Data collection occurred between
February 2011 and June 2012.

Analysis
After the interviews were transcribed verbatim and
checked for accuracy, a descriptive thematic approach was used to complete the analysis (Miles

& Huberman, 1994; Saldana, 2009). The intent
was to analyze the meaning and importance of
breastfeeding infants with PKU from the perspectives of their mothers. Rules and definitions were
created to ensure that coding occurred consistently throughout the narratives (Miles & Huberman, 1994; Saldana, 2009). For this analysis,
coded data from all interviews that were related
to the meaning and importance of breastfeeding an infant with PKU were reviewed. Mothers’
descriptions of the meaning and importance of
breastfeeding an infant with PKU were grouped
together to form categories. Thematically similar categories and data were combined to form
themes. Emerging themes were compared among
transcripts during data analysis to establish their
linkages across categories (Ayres, Kavanaugh, &
Knafl, 2003).
Several techniques were implemented to enhance
the study quality. To ensure consistent style of interviewing, the principal investigator completed all
the interviews. To address researcher bias that
might influence analysis, initial transcripts were
reviewed by coauthors who found no evidence of
leading questions or inappropriate probing. Coauthors also provided input throughout the analysis
on the development of coding categories, the coding process, and the interpretation of study results.
Differences in coding were resolved with conferencing among team members to reach consensus
about coding, and to confirm agreement on the
overarching theme and subthemes (Patton, 2002).

To enhance the trustworthiness of the data, a detailed audit trail was maintained that documented
all methodological and analytical decisions.

Results
Labor of Love
The central theme Labor of Love reflected the
commitment of mothers to breastfeed despite a
diagnosis of PKU. Prior to diagnosis, mothers exclusively breastfed their infants. In so doing, they
expressed their support of the benefits of breastfeeding and breast milk. Mothers reported that
following the diagnosis of PKU they decided to
continue breastfeeding, even though this required
increased effort. For these mothers, breastfeeding
required that they prepare and bottle feed Phefree medical formula as instructed by a health
care provider (usually a dietitian) to maintain
their infants’ Phe levels within the desired range.
Sometimes expressed breast milk or standard
commercial infant formula was required in addition
to the medical formula. These mothers needed
to breast pump to maintain their breast milk supplies. Pumping included the time to pump, clean
pumping equipment after each use, and store expressed breast milk in appropriate containers for
freezing or refrigeration. Mothers linked their willingness to undertake the extra work of breastfeeding to their commitment to doing what was best for
the infants.
During this time, mothers also were orchestrating the care of their infants. As one mother
commented, “It would be easier if I could just

breastfeed him. But, I can’t. It would be easier if he
was exclusively formula fed, but he’s not.” Mothers wanted to provide the best nutrition to their infants and believed the extra work required to continue breastfeeding was worth the effort. For these
mothers, breastfeeding in the context of PKU was
truly a labor of love, and this commitment broadens the definition of successful breastfeeding in
this unique group of mothers. See Figure 1 for a
summary of the main and subthemes.
Committing to Breastfeed After the Diagnosis. The
first subtheme we identified was Committing to
Breastfeed After the Diagnosis. Although all mothers planned on breastfeeding, after diagnosis they
explored the option to continue to breastfeed. Ultimately, they recommitted to breastfeeding despite the diagnosis. Recommitting entailed quickly
learning about PKU and the special nutritional
needs of their infants. Mothers described a steep
learning curve as they came to understand the disorder more fully and implications for their infants
and family. One mother described continuing to
breastfeed as a relief that was made possible by
support from the clinic’s staff:
Because the clinic supported it, our doctor
was very into the “breastfeeding was best.”
It really wasn’t a choice. It wasn’t a decision.
It was already our plan. Thus, we didn’t have
to deviate from our plan. It was a relief that
we were able to keep doing it.
Other mothers described their decisions to recommit to breastfeeding as based on the realization
that breast milk was lower in Phe than standard

Figure 1. Themes and subthemes related to participants’ commitment to breastfeed in the context of PKU.
Note. Phe = phenylalanine, PKU = phenylketonuria.

commercial infant formula, the closeness between
mother and infant, and the regular nutritional benefits of breast milk for infants:
Our dietitian said at the very beginning
about how breast milk was ... lower in
phenylalanine than [the standard commercial infant] formula. In my mind, that meant
that it would be better for me to keep trying
to give him breast milk as much as I could.
Another mother stated:
It really did not make sense to me that since
he still needed natural protein in this diet
[why not give him] ... the most natural protein ... breast milk. It just added to the argument of why I should continue.
Breastfeeding symbolized the continuation of the
unique biological connection between the mother
and infant. Mothers described the experience as a
special “closeness” or “bonding” that they felt with
their infants because of breastfeeding, “Knowing
that it was a way that I could bond with her.... It
was easy to continue to breastfeed her because I
knew that it was the best thing for her.”
Although mothers articulated the general benefits of breast milk, a few mothers decided to continue to breastfeed to mitigate the effects of PKU,
because breast milk could improve their infants’
cognitive and neurological outcomes:
I knew that breast milk would provide benefits that could not be matched with [standard commercial infant] formula. I also knew
that breastfed babies tended to have higher
IQs. I thought that if she is going to be in
a position where her IQ would already be
lower that it would make more sense to me
to do everything that I could to protect her
brain. Maybe the breast milk would counter
balance it a little bit.
Consequently, their infants continued to breastfeed and received the benefits of breast milk and
breastfeeding.
Adapting Breastfeeding to Maintain Phe Levels.
The second subtheme related to adapting breastfeeding, which meant mothers had the patience
and perseverance to make breastfeeding work
while maintaining Phe levels. One mother shared
modifying her breastfeeding plans as, “You do
what you need to do.” Immediately after diagnosis,
mothers used a variety of approaches to combine

Mothers wanted to provide the best nutrition for their infants
with phenylketonuria, which meant limiting breastfeeding while
bottle feeding phenylalanine-free medical formula.

breastfeeding and bottle feeding Phe-free medical
formula that ranged from offering a small amount
of medical formula at each feeding to alternating
breastfeeding and bottle feeding medical formula.
In addition, mothers developed creative strategies
to encourage their infants to bottle feed Phe-free
medical formula, such as regulating the temperature of the formula, combining expressed breast
milk with the formula, and using specific bottles
and nipples.
These mothers worked through numerous challenges presented by fluctuating Phe levels and
ever-changing treatment plans:
I breastfed for 7 months. During that time,
[how much I could breastfed] ... fluctuated
because we monitored [Phe] levels every
week. I would have to increase breastfeeding if levels were too low and decrease
breastfeeding if they went too high.
The majority of the mothers realized shortly after
the PKU diagnosis that they needed to be proactive to maintain their breast milk supplies, and they
started breast pumping after feeding their infants
the medical formula. Nonetheless, mothers also
reported it was a challenge to keep up a milk supply even with a “powerful” breast pump:
Having a good pump, a really good pump,
really did it because the issues that arise
with breastfeeding and simultaneously bottle feeding are always related to supply.
Because your infant has not nursed as
frequently as an exclusively breastfed baby,
your supply can wane.
For some mothers even routine pumping after
bottle feeding medical formula was not enough
to keep up their milk supplies. A few mothers
were prescribed domperidone, and others were
encouraged to use herbal supplements to boost
their breast milk supply in combination with
breast pumping and breastfeeding. They also
reported that “finding the time to breast pump
... wasn’t easy” while continuing with their other
household duties, child care responsibilities, and
for some, returning to their careers. Yet mothers
persisted and described how they integrated
breast pumping into their busy schedules.

Accessing Breastfeeding Support. The third subtheme to emerge was related to supportive resources used by mothers to help them
maintain their commitment to breastfeeding. Mothers sought out resources and support from other
mothers who had breastfed or were currently
breastfeeding infants with PKU and who understood what they were going through. Some were
able to locate another mother close by, and these
one-on-one exchanges provided participants with
the support they needed to continue breastfeeding: “When my son was about 2 months old, I
talked with another mom who had breastfed her
son with PKU ... for almost 11 months that encouraged me and definitely kept me going toward the
end.”
However, most mothers were unable to find another mother who lived within their geographical
area and instead sought support via the Internet:
I joined the PKU Listserv ... I started sending out emails: Need breastfeeding advice,
Having supply issues with PKU baby – How
do you increase, how did you increase your
supply from mothers who have done it? How
did you manage? ... I had 20 responses
within 24 hours.... They (wrote) this is what I
did, this is how we managed, and this is
what my clinic expected. My experience
with the Listserv in getting all those responses was a positive thing.
Other mothers who joined the PKU Listserv also
found it a valuable resource. Although they did
not all post questions, they learned from various
conversations covering topics of interest.
Even though there are many members of the
metabolic team, dietitians were identified by all
mothers as the primary support. One mother
shared, “Our dietitian was extremely helpful and
said, ‘Your breast milk is good for her. This is the
right thing to do.’ She was very supportive that
way.” The majority of mothers also identified their
husbands as supportive of breastfeeding, “I had
a husband who believed in it [breastfeeding]. He
really believed that breastfeeding was the best
thing.” In addition, mothers received support from
family and friends who lived nearby:
Most of the breastfeeding information, I got
from my mom from resources that she had.
I think that her breastfeeding knowledge
base really helped. She called almost every
lactation consultant that she knew and they
all kind of teamed up ... I think that if she

had not been as supportive that it [breastfeeding] would have been harder.

All mothers were able to find information about
PKU or information about breastfeeding but not
breastfeeding infants with PKU, “I tried to go on
the web to do some searches. I found a lot of
information on breastfeeding in general, but not
on breastfeeding and PKU.” Mothers identified a
clear lack of written information about breastfeeding infants with PKU and any written support was
dependent on their ability to integrate information
from these two disparate bodies of knowledge.

Breastfeeding Rewards. The fourth subtheme reflected the belief that in spite of the breastfeeding
challenges, the rewards outweighed the work associated with breastfeeding infants with PKU:
I am so grateful that we were able to still
breastfeed her. Even with the cracked and
bleeding nipples, the thrush.... It wasn’t always very fun and it made me cry. I’m really
grateful that we were able to breastfeed as
I believe that it [breastfeeding] is the best
thing.

In committing to continue breastfeeding after the
diagnosis, these mothers carried out a unique maternal activity that contributed to their views of
themselves as good mothers:
It’s been really great because I never
wanted to look back ... at his first year and
say I wish that I could have done something
differently. I think when you find out that you
have a child with PKU that you kind of overanalyze their development. I think for a long
time that I would get really hung up on “well,
he is not looking at me” and “he crawled a
lot later than his sibling. He is definitely behind in gross motor, but he is not at all developmentally delayed.” His doctors are like
“he is totally on track.” For a long time I really
didn’t believe that, but now [I see him] doing
really so well. His verbal skills are great. His
fine motor skills are awesome. He is so communicative. He is so smart. I feel so proud
of myself. I have no idea if breastfeeding
had any correlation to that, but I think that if
I hadn’t done that, I might have thought that
well maybe I would have done something
differently. So I think that it [breastfeeding]
really was a labor of love.

Over time, these mothers began to view their infants as normal, healthy children who happened
to have PKU. This was in part a validation of
their breastfeeding decisions. Breastfeeding gave
them a way to view their infants as normal and to
achieve a sense of normalcy in everyday life. One
mother summed it up: “He has PKU, but he isn’t
PKU. It is just one aspect of his life. It is not his
whole life.”

Discussion
In this study, we explored the meaning and importance of breastfeeding to mothers with infants
diagnosed with PKU. The reports of their experiences revealed the depth and breadth of their
commitment to continue breastfeeding after the diagnosis. Although many of the experiences of the
mothers were similar to those of mothers of term
infants, this study provided valuable insights into
the commitment that is necessary to breastfeed
an infant with PKU. Several researchers reported
that being committed to breastfeeding influenced
mothers to persist with breastfeeding their term infants (Blyth et al., 2002; Bottorff, 1990; Humenick,
Hill, & Wilhelm, 1997; Nelson & Sethi, 2005). In this
study, the theme of commitment provided a way
to understand and characterize the participants’
unique experiences. Their commitment to breastfeeding was evident in their decisions to continue
breastfeeding after diagnosis. This decision required that they adapt breastfeeding to manage
PKU and to overcome challenges they faced with
common breastfeeding problems and fluctuating
Phe levels. Thus, the commitment to breastfeeding
was a labor of love.
Fluctuating Phe levels provided many challenges,
including ever-changing treatment plans and increased workload of breastfeeding, bottle feeding, and breast pumping. Despite weekly to twice
weekly adaptations in breastfeeding plans, mothers continued to supply their infants with the best
natural source of nutrition. At any time they could
have stopped or given up, but instead they made
a commitment to breastfeed their infants that tied
them to their infants in a special way. This aspect
of laboring out of love and commitment to continue
breastfeeding broadens the definition of successful breastfeeding in this unique group of mothers.
For mothers of healthy term infants, there are
usually many options for help with breastfeeding
issues, such as breastfeeding clinics and postpartum nurses, as well as friends and family. Many resources are available at the library, in book stores,
and in lay journals. Even mothers of infants who

Mothers wanted more support and encouragement from their
families, friends, and health care providers as they continued to
breastfeed after the diagnosis of phenylketonuria.

are preterm or critically ill and in the NICU have
available resources in the nurses who care for their
infants who are premature or critically ill, in-house
lactation consultants, and other mothers who have
or are breastfeeding/breast pumping for their infants. Since Meier’s research on breastfeeding the
premature infant (Meier, 2001, 2003b; Meier et al.,
2000; Meier et al., 2008; Meier, Engstrom, Janes,
Jegier, & Loera, 2012; Meier, Furman, & Degenhardt, 2007), there has been a growing knowledge base about breastfeeding the infants who
are the smallest and most critically ill. Related publications have been published in lay journals and
pamphlets typically available in the NICU. No such
resources are available for mothers who wish to
breastfeed infants with PKU.
In this study, mothers struggled to locate written
information about breastfeeding infants with PKU.
We searched for resources for mothers who are
breastfeeding infants with PKU. We found Tips
for Breastfeeding a Baby With PKU (PKU News,
2006). Unfortunately, this web page has not been
updated in 9 years. Even the most recent edition
of Breastfeeding: A Guide for the Medical Profession (Lawrence & Lawrence, 2010) falls short: the
section on breastfeeding infants with PKU cites
the Ernest et al. (1980) study, which is no longer
available from the publisher. Consequently, there
is a lack of current, evidence-based information
for these mothers who want and need resources
related to breastfeeding infants with PKU similar to
those developed for breastfeeding premature infants (Meier, 2003aa). To fill this gap, a resource for
breastfeeding infants with PKU is being developed
in association with the National PKU Alliance.
This study provides the first thematic description
from mothers’ perspectives of the meaning and
importance of breastfeeding infants with PKU and
also extends knowledge of the needs of these
mothers. Research in this area will provide a scientific base from which to design and test evidencebased strategies to help these mothers. In
addition, education can provide clinicians with
tools to support mothers to successfully breastfeed their infants with PKU. Finally, research about
human milk and lactation that includes infants with
inborn errors of metabolism, such as PKU, will be
important to inform clinicians and parents alike.

Implications for Practice
Our findings suggest that nurses working with
mothers should be alert to their need for support
and encouragement to breastfeed after diagnosis
of PKU. The emphasis that mothers in the study
placed on support and encouragement suggests
that they want more support from their families,
friends, and health care providers. As mothers integrate two different bodies of knowledge related
to breastfeeding and PKU, they need to have their
concerning questions answered in a timely fashion. In addition, mothers want words of encouragement as breastfeeding an infant with PKU is
challenging and disheartening at times. Providing
support also means providing anticipatory guidance. To be able to continue breastfeeding while
supplementing with Phe-free medical formula,
mothers need a powerful breast pump to help
them maintain breast milk supplies. Mothers
should be encouraged to obtain hospital-quality
electric breast pumps with double collection kits
so that both breasts are emptied simultaneously
and for long-term breast pumping. The nurse
can provide a list of convenient places to obtain
a hospital-quality electric breast pump and
should discourage the use of smaller electric
or battery-operated breast pumps that seldom
provide adequate breast stimulation to maintain
an adequate milk supply. In addition, nurses can
work with mothers to develop a breast pumping
schedule while incorporating PKU management,
integrating other family responsibilities, and for
some, returning to their careers.

PKU were interviewed regarding the meaning and
importance of breastfeeding in this situation. Analysis of the interviews with mothers revealed one
central theme, Labor of Love: Commitment to
Breastfeeding in the Context of PKU. The experiences of the participants demonstrated their commitment to breastfeeding despite the diagnosis of
PKU, the importance mothers attribute to breastfeeding, and their willingness to invest considerable effort to breastfeed.
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